Ardelyx to Present at the Jefferies Virtual London Healthcare Conference
FREMONT, Calif., Nov. 10, 2020 /PRNewswire/ -- Ardelyx Inc.. (Nasdaq: ARDX), a biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for people with kidney and cardiovascular diseases, today announced that Mike Raab, president and chief executive officer of Ardelyx, will participate in a fireside chat at the Jefferies Virtual London Healthcare Conference on Tuesday, November 17, 2020 at 1:10 p.m. ET.
To access the live webcast of Ardelyx's presentation please visit the Events & Presentations page within the Investor section of the Ardelyx website at https://ir.ardelyx.com/events-and-presentations. A replay of the webcast will be available on the Ardelyx website for 60 days following the presentation.
About Ardelyx, Inc.
View original content to download multimedia:http://www.prnewswire.com/news-releases/ardelyx-to-present-at-the-jefferies-virtual-london-healthcare-conference-301169441.html
Company Codes: NASDAQ-NMS:ARDX